Pomarici, Nancy D.
Waibl, Franz
Quoika, Patrick K.
Bujotzek, Alexander
Georges, Guy
Fernández-Quintero, Monica L.
Liedl, Klaus R.
Funding for this research was provided by:
Austrian Science Fund (P34518, P34518, P34518, P34518, P34518)
Austrian Science Fund
Article History
Received: 2 January 2023
Accepted: 23 February 2023
First Online: 15 March 2023
Declarations
:
: G.G. and A.B. are Roche employees and own Roche stocks; Roche has an interest in developing antibody-based therapeutics.